imatinib teva pharma 400 mg film-coated tablets
teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - imatinib - film-coated tablet - imatinib 400 mg - antineoplastic agents
valaciclovir teva 500 mg film-coated tablets
teva pharma b.v. - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir
abacavir/lamivudine teva 600 mg/300 mg film-coated tablets
teva b.v. - abacavir; lamivudine - film-coated tablet - 600 mg/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir
entecavir teva 0.5 mg film-coated tablets
teva b.v. - entecavir - tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir
t t o p herbicide adjuvant
profitplus a division of teva corp - nonionic & anionic surfactants - wetting agent - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - wetting agent (use as directed) | improve penetrating properties
ams rage herbicide adjuvant
profitplus a division of teva corp - nonionic & anionic surfactants - wetting agent - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - wetting agent (use as directed) | improve penetrating properties
capecitabine teva 150 mg
abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 150 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukesע stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.
capecitabine teva 500 mg
abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 500 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.
ramipril teva
teva pharma b.v. - ramipril - tablets - 1.25 milligram
ramipril teva
teva pharma b.v. - ramipril - tablets - 2.5 milligram